Multiomics and Artificial Intelligence for Personalized Nutritional Management of Diabetes in Patients Undergoing Peritoneal Dialysis

Overview

Journal Adv Nutr

Publisher Elsevier

Date 2025 Jan 22

PMID 39842720

Authors

Sara Mahdavi

Nicole M Anthony

Tabo Sikaneta

Paul Y Tam

Affiliations

Soon will be listed here.

Abstract

Managing diabetes in patients on peritoneal dialysis (PD) is challenging due to the combined effects of dietary glucose, glucose from dialysate, and other medical complications. Advances in technology that enable continuous biological data collection are transforming traditional management approaches. This review explores how multiomics technologies and artificial intelligence (AI) are enhancing glucose management in this patient population. Continuous glucose monitoring (CGM) offers significant advantages over traditional markers, such as hemoglobin A1c (HbA1c). Unlike HbA1c, which reflects an mean glucose level, CGM provides real-time, dynamic glucose data that allow clinicians to make timely adjustments, leading to better glycemic control and outcomes. Multiomics approaches are valuable for understanding genetic factors that influence susceptibility to diabetic complications, particularly those related to advanced glycation end products (AGEs). Identifying genetic polymorphisms that modify a patient's response to AGEs allows for personalized treatments, potentially reducing the severity of diabetes-related pathologies. Metabolomic analyses of PD effluent are also promising, as they help identify early biomarkers of metabolic dysregulation. Early detection can lead to timely interventions and more tailored treatment strategies, improving long-term patient care. AI integration is revolutionizing diabetes management for PD patients by processing vast datasets from CGM, genetic, metabolic, and microbiome profiles. AI can identify patterns and predict outcomes that may be difficult for humans to detect, enabling highly personalized recommendations for diet, medication, and dialysis management. Furthermore, AI can assist clinicians by automating data interpretation, improving treatment plans, and enhancing patient education. Despite the promise of these technologies, there are limitations. CGM, multiomics, and AI require significant investment in infrastructure, training, and validation studies. Additionally, integrating these approaches into clinical practice presents logistical and financial challenges. Nevertheless, personalized, data-driven strategies offer great potential for improving outcomes in diabetes management for PD patients.

References

Garibotto G, Sofia A, Saffioti S, Bonanni A, Mannucci I, Parodi E . Effects of peritoneal dialysis on protein metabolism. Nutr Metab Cardiovasc Dis. 2012; 23 Suppl 1:S25-30. DOI: 10.1016/j.numecd.2012.07.005. View

Aragones G, Rowan S, Francisco S, Whitcomb E, Yang W, Perini-Villanueva G . The Glyoxalase System in Age-Related Diseases: Nutritional Intervention as Anti-Ageing Strategy. Cells. 2021; 10(8). PMC: 8393707. DOI: 10.3390/cells10081852. View

Gupta S, Sharma N, Arora S, Verma S . Diabetes: a review of its pathophysiology, and advanced methods of mitigation. Curr Med Res Opin. 2024; 40(5):773-780. DOI: 10.1080/03007995.2024.2333440. View

Pan J, Xu X, Wang Z, Ma T, Dong J . Dietary Potassium and Clinical Outcomes among Patients on Peritoneal Dialysis. Nutrients. 2023; 15(19). PMC: 10574508. DOI: 10.3390/nu15194271. View

Levin A, Bakris G, Molitch M, Smulders M, Tian J, Williams L . Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int. 2006; 71(1):31-8. DOI: 10.1038/sj.ki.5002009. View

Nayak Karopadi A, Mason G, Rettore E, Ronco C . Cost of peritoneal dialysis and haemodialysis across the world. Nephrol Dial Transplant. 2013; 28(10):2553-69. DOI: 10.1093/ndt/gft214. View

Foo M, Htay H . Innovations in peritoneal dialysis. Nat Rev Nephrol. 2020; 16(10):548-549. DOI: 10.1038/s41581-020-0283-8. View

Borrelli S, De Nicola L, De Gregorio I, Polese L, Pennino L, Elefante C . Volume-Independent Sodium Toxicity in Peritoneal Dialysis: New Insights from Bench to Bed. Int J Mol Sci. 2021; 22(23). PMC: 8657906. DOI: 10.3390/ijms222312804. View

Karageorgos F, Neiros S, Karakasi K, Vasileiadou S, Katsanos G, Antoniadis N . Artificial kidney: Challenges and opportunities. World J Transplant. 2024; 14(1):89025. PMC: 10989479. DOI: 10.5500/wjt.v14.i1.89025. View

10.

Theodore Armand T, Nfor K, Kim J, Kim H . Applications of Artificial Intelligence, Machine Learning, and Deep Learning in Nutrition: A Systematic Review. Nutrients. 2024; 16(7). PMC: 11013624. DOI: 10.3390/nu16071073. View

11.

Tian N, Yan Y, Chen N, Xu S, Chu R, Wang M . Relationship between gut microbiota and nutritional status in patients on peritoneal dialysis. Sci Rep. 2023; 13(1):1572. PMC: 9884196. DOI: 10.1038/s41598-023-27919-3. View

12.

Manley K . Taste genetics and gastrointestinal symptoms experienced in chronic kidney disease. Eur J Clin Nutr. 2015; 69(7):781-5. DOI: 10.1038/ejcn.2015.80. View

13.

Guo S, Wu H, Ji J, Sun Z, Xiang B, Wu W . Association between gut microbial diversity and technique failure in peritoneal dialysis patients. Ren Fail. 2023; 45(1):2195014. PMC: 10071986. DOI: 10.1080/0886022X.2023.2195014. View

14.

Ni Y, Zheng L, Nan S, Ke L, Fu Z, Jin J . Enterorenal crosstalks in diabetic nephropathy and novel therapeutics targeting the gut microbiota. Acta Biochim Biophys Sin (Shanghai). 2022; 54(10):1406-1420. PMC: 9827797. DOI: 10.3724/abbs.2022140. View

15.

Davani-Davari D, Negahdaripour M, Karimzadeh I, Seifan M, Mohkam M, Masoumi S . Prebiotics: Definition, Types, Sources, Mechanisms, and Clinical Applications. Foods. 2019; 8(3). PMC: 6463098. DOI: 10.3390/foods8030092. View

16.

Egana-Gorrono L, Lopez-Diez R, Yepuri G, Ramirez L, Reverdatto S, Gugger P . Receptor for Advanced Glycation End Products (RAGE) and Mechanisms and Therapeutic Opportunities in Diabetes and Cardiovascular Disease: Insights From Human Subjects and Animal Models. Front Cardiovasc Med. 2020; 7:37. PMC: 7076074. DOI: 10.3389/fcvm.2020.00037. View

17.

Jandhyala S, Talukdar R, Subramanyam C, Vuyyuru H, Sasikala M, Reddy D . Role of the normal gut microbiota. World J Gastroenterol. 2015; 21(29):8787-803. PMC: 4528021. DOI: 10.3748/wjg.v21.i29.8787. View

18.

Badura K, Janc J, Wasik J, Gnitecki S, Skwira S, Mlynarska E . Anemia of Chronic Kidney Disease-A Narrative Review of Its Pathophysiology, Diagnosis, and Management. Biomedicines. 2024; 12(6). PMC: 11200696. DOI: 10.3390/biomedicines12061191. View

19.

Miyajima Y, Karashima S, Mizoguchi R, Kawakami M, Ogura K, Ogai K . Prediction and causal inference of hyperuricemia using gut microbiota. Sci Rep. 2024; 14(1):9901. PMC: 11061287. DOI: 10.1038/s41598-024-60427-6. View

20.

Hernandez Medina R, Kutuzova S, Nielsen K, Johansen J, Hansen L, Nielsen M . Machine learning and deep learning applications in microbiome research. ISME Commun. 2023; 2(1):98. PMC: 9723725. DOI: 10.1038/s43705-022-00182-9. View